{"DataElement":{"publicId":"2646723","version":"1","preferredName":"NCCTG Patient N063D Inclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of clinical trial eligibility criteria for NCCTG N063D protocol for elements iof a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"NCCTG_P_O63D_CTEC_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2646709","version":"1","preferredName":"NCCTG Patient Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information related to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"NCCTG_PT_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2646707","version":"1","preferredName":"North Central Cancer Treatment Group Patient","preferredDefinition":"The North Central Cancer Treatment Group (NCCTG) is a national clinical research group sponsored by the NCI. The research base for NCCTG is located at Mayo Clinic in Rochester, Minn. NCCTG consists of a network of more than 1,000 cancer specialists at community clinics, hospitals and medical centers in 25 states in US, two Canadian provinces and Mexico. NCCTG specializes in researching methods of treating and preventing cancer, and in researching methods to alleviate the side effects of cancer and cancer treatments.:A person who requires medical care.","longName":"C25581:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"North Central Cancer Treatment Group","conceptCode":"C25581","definition":"A national clinical research group sponsored by the NCI. The research base for NCCTG is located at Mayo Clinic in Rochester, Minn. NCCTG consists of a network of more than 1,000 cancer specialists at community clinics, hospitals and medical centers in 25 states in US, two Canadian provinces and Mexico. NCCTG specializes in researching methods of treating and preventing cancer, and in researching methods to alleviate the side effects of cancer and cancer treatments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A1EC6-A8FA-1E06-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518229","version":"1","preferredName":"Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"The addition of somebody or something to, or the presence of somebody or something in, a group or mixture, particularly, a passive, usually temporary, product of cell activity within the cytoplasm or nucleus.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25532:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inclusion Criteria","conceptCode":"C25532","definition":"Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08D4-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A1EC6-A908-1E06-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2646710","version":"1","preferredName":"N063D Inclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of inclusion clinical trial eligibility criteria for NCCTG N063D protocol.","longName":"N063D_I_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Age >= 18 years","valueDescription":">= 18 years of age","ValueMeaning":{"publicId":"2625936","version":"1","preferredName":">= 18 years of age","longName":"2625936","preferredDefinition":">= 18 years of age","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DB3082C-52A5-1CB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A5BAC-33D4-2255-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Eastern Cooperative Oncology Group (ECOG) performance status < 1","valueDescription":"Eastern Cooperative Oncology Group (ECOG) performance status < 1","ValueMeaning":{"publicId":"2646712","version":"1","preferredName":"Eastern Cooperative Oncology Group (ECOG) performance status < 1","longName":"2646712","preferredDefinition":"Eastern Cooperative Oncology Group (ECOG) performance status < 1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A4F69-20B2-1699-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A5BAC-33E5-2255-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Non-metastatic operable primary invasive adenocarcinoma of the breast","valueDescription":"Non-metastatic operable primary invasive adenocarcinoma of the breast","ValueMeaning":{"publicId":"2646713","version":"1","preferredName":"Non-metastatic operable primary invasive adenocarcinoma of the breast","longName":"2646713","preferredDefinition":"Non-metastatic operable primary invasive adenocarcinoma of the breast","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A52BA-FC99-16D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A5BAC-33F7-2255-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Known hormone receptor status (ER/PgR or ER alone)","valueDescription":"Known hormone receptor status (ER/PgR or ER alone)","ValueMeaning":{"publicId":"2646714","version":"1","preferredName":"Known hormone receptor status (ER/PgR or ER alone)","longName":"2646714","preferredDefinition":"Known hormone receptor status (ER/PgR or ER alone)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A55B5-C3FB-250E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A5BAC-3409-2255-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Must have received at least four cycles of an approved anthracycline-based (neo-) adjuvant chemotherapy regimen","valueDescription":"Must have received at least four cycles of an approved anthracycline-based (neo-) adjuvant chemotherapy regimen","ValueMeaning":{"publicId":"2646715","version":"1","preferredName":"Must have received at least four cycles of an approved anthracycline-based (neo-) adjuvant chemotherapy regimen","longName":"2646715","preferredDefinition":"Must have received at least four cycles of an approved anthracycline-based (neo-) adjuvant chemotherapy regimen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A5502-57FB-1D2E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A5BAC-341B-2255-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Baseline LVEF > 50% measured by echocardiography or MUGA scan after completion of all anthracycline-based (neo-) adjuvant chemotherapy and prior to the targeted therapy(ies)","valueDescription":"Baseline LVEF > 50% measured by echocardiography or MUGA scan after completion of all anthracycline-based (neo-) adjuvant chemotherapy and prior to the targeted therapy(ies)","ValueMeaning":{"publicId":"2646716","version":"1","preferredName":"Baseline LVEF > 50% measured by echocardiography or MUGA scan after completion of all anthracycline-based (neo-) adjuvant chemotherapy and prior to the targeted therapy(ies)","longName":"2646716","preferredDefinition":"Baseline LVEF > 50% measured by echocardiography or MUGA scan after completion of all anthracycline-based (neo-) adjuvant chemotherapy and prior to the targeted therapy(ies)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A5502-580B-1D2E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A55B5-C430-250E-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Overexpression and/or amplification of HER2 in the invasive component of the primary tumor","valueDescription":"Overexpression and/or amplification of HER2 in the invasive component of the primary tumor","ValueMeaning":{"publicId":"2646718","version":"1","preferredName":"Overexpression and/or amplification of HER2 in the invasive component of the primary tumor","longName":"2646718","preferredDefinition":"Overexpression and/or amplification of HER2 in the invasive component of the primary tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A52BA-FCA9-16D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A6CB9-783F-2295-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Completion of all necessary baseline laboratory and radiological investigations","valueDescription":"Completion of all necessary baseline laboratory and radiological investigations","ValueMeaning":{"publicId":"2646720","version":"1","preferredName":"Completion of all necessary baseline laboratory and radiological investigations","longName":"2646720","preferredDefinition":"Completion of all necessary baseline laboratory and radiological investigations","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A52BA-FCB9-16D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"321A4F69-20C9-1699-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"},{"value":"Signed written informed consent","valueDescription":"Signed written informed consent","ValueMeaning":{"publicId":"2646721","version":"1","preferredName":"Signed written informed consent","longName":"2646721","preferredDefinition":"Signed written informed consent","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A4F69-20D4-1699-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3218FAA8-F4C8-1631-E044-0003BA3F9857","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"ONEDATA","dateModified":"2007-06-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"321A3142-E407-2172-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Inclusion Criteria","type":"Preferred Question Text","description":"Inclusion Criteria","url":null,"context":"CTEP"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3219C3D4-7A30-2FDD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-04","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}